<p>Collections of SLE patients with number of patients available for analysis.</p
<p>Number of treatment options under various scenarios in the Hospital database.</p
<p>Stratification analysis of the clinical measures in patients following regular therapy for SLE.</...
<p>Number of patients who required oxygen therapy by disease group and individual diagnosis.</p
Number of serum specimens, number of contributing patients, and age of patients by specimen type.</p
<p>Clinical characteristics of the patients with SLE included in the analyses.</p
<p>Description of the number of persons included and the number of patients used in our analysis.</p
Demographic features, clinical and laboratory manifestations and treatment of 120 SLE patients.</p
<p>Number of VL patient admissions per year and number of clinical records available for analysis.</...
<p>Number of patients enrolled to the study at the two community clinics, according to final diagnos...
<p>Clinicopathological data of the 185 breast cancer patients included in the analysis.</p
The number of available subjects in each diagnostic group for annual follow-up visits.</p
<p>Demographic and disease manifestation in SLE patients and healthy controls.</p
The alpha-diversity indices between SLE patients (red) and healthy controls (blue).</p
<p>The number of patients in the training and test datasets for childhood leukaemia dataset.</p
<p>Distribution of American College of Rheumatology (ACR) 1982 classification criteria for the 148 S...
<p>Number of treatment options under various scenarios in the Hospital database.</p
<p>Stratification analysis of the clinical measures in patients following regular therapy for SLE.</...
<p>Number of patients who required oxygen therapy by disease group and individual diagnosis.</p
Number of serum specimens, number of contributing patients, and age of patients by specimen type.</p
<p>Clinical characteristics of the patients with SLE included in the analyses.</p
<p>Description of the number of persons included and the number of patients used in our analysis.</p
Demographic features, clinical and laboratory manifestations and treatment of 120 SLE patients.</p
<p>Number of VL patient admissions per year and number of clinical records available for analysis.</...
<p>Number of patients enrolled to the study at the two community clinics, according to final diagnos...
<p>Clinicopathological data of the 185 breast cancer patients included in the analysis.</p
The number of available subjects in each diagnostic group for annual follow-up visits.</p
<p>Demographic and disease manifestation in SLE patients and healthy controls.</p
The alpha-diversity indices between SLE patients (red) and healthy controls (blue).</p
<p>The number of patients in the training and test datasets for childhood leukaemia dataset.</p
<p>Distribution of American College of Rheumatology (ACR) 1982 classification criteria for the 148 S...
<p>Number of treatment options under various scenarios in the Hospital database.</p
<p>Stratification analysis of the clinical measures in patients following regular therapy for SLE.</...
<p>Number of patients who required oxygen therapy by disease group and individual diagnosis.</p